{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO20252 COVID-19 Vaccine handling and management policy 1.20.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "COVID-19 VACCINE HANDLING AND MANAGEMENT POLICY 2020-21"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-20252"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.20"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All NHS staff responsible for planning and managing the COVID-19 vaccination programme in 2020/21, and all NHS Pharmacy staff engaged in supporting and delivering the COVID-19 vaccination programme in 2020/21"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "06 December 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Model NHS COVID-19 Vaccine handling and management policy 2020-21 Pharmacy Institutional Readiness for Management of Pfizer-BioNTech (Courageous) Covid-19 vaccine (SPS 2020) Legal Mechanisms for administration of the COVID-19 Vaccine(s)"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Evelyn Allen \u2013 Chief Pharmacist Chris Overland \u2013 Pharmacy Business Manager Richard Ketley \u2013 Principal Pharmacist Medication Safety"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSE Medicines Assurance Committee (MAC) (Chairman Approval)"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Evelyn Allen \u2013 Chief Pharmacist"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group \u2013 chairs approval"
                    },
                    {
                        "text": "04 December 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "December 20"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO20252 COVID-19 Vaccine handling and management policy 1.20.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Tom Abell"
                    },
                    {
                        "text": "Deputy Chief Executive"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "Denise Townsend"
                    },
                    {
                        "text": "Deputy Chief Nurse / Director Governance, Risk and Compliance"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "David Walker"
                    },
                    {
                        "text": "Chief Medical Officer"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "Michelle Stapleton"
                    },
                    {
                        "text": "Director of Operations Care Group 4"
                    },
                    {
                        "text": "07 December 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Policy for the Prescribing of Medicines (or equivalent) Policy for the Administration of Medicines (or equivalent) Policy for the Safe & Secure Handling of Medicines (or equivalent) Policy for the management of occupational sharps and contamination injuries (or equivalent)MSEPO-20205 Policy for Safe and Secure Storage of Medicines MSEPO-20210 Development Approval and Implementation of PGDs Policy"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 17,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Revie wer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Evelyn Allen / Richard Ketley"
                    },
                    {
                        "text": "New document"
                    },
                    {
                        "text": "07 December 2020"
                    },
                    {
                        "text": "1.1"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Updated Appendix 1 (PSD) following national guidance issued 8/12/20"
                    },
                    {
                        "text": "09 December 2020"
                    },
                    {
                        "text": "1.2"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Updated Appendix 1 (PSD) following national guidance issued 11/12/20"
                    },
                    {
                        "text": "11 December 2020"
                    },
                    {
                        "text": "1.3"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "thUpdated Appendix 2 (SOP) to enable 6 dose from vial"
                    },
                    {
                        "text": "30 December 2020"
                    },
                    {
                        "text": "1.4"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Appendices updated, no stand-alone only."
                    },
                    {
                        "text": "08 January 2021"
                    },
                    {
                        "text": "1.5"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Addition of section 16 and related responsibilities to 4.2.6 and 4.2.8. Addition of Appendix 6 & 7"
                    },
                    {
                        "text": "20 January 2021"
                    },
                    {
                        "text": "1.6"
                    },
                    {
                        "text": "Richard Ketley Chris Overland"
                    },
                    {
                        "text": "Addition of Appendix 8"
                    },
                    {
                        "text": "10 February 2021"
                    },
                    {
                        "text": "1.7"
                    },
                    {
                        "text": "Richard Ketley Chris Overland"
                    },
                    {
                        "text": "Addition of Appendix 9, 10, 11 & 12. Minor rewording to sections 5.5, 7.4.5, 8.2, 8.4, 10.2 & 10.3 so applies to multiple vaccine types."
                    },
                    {
                        "text": "16 February 2021"
                    },
                    {
                        "text": "1.8"
                    },
                    {
                        "text": "Richard Ketley Chris Overland"
                    },
                    {
                        "text": "Updated Appendix 1 and addition of Appendix 13 and 14"
                    },
                    {
                        "text": "19 February 2021"
                    },
                    {
                        "text": "1.9"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Minor updates to Appendices 2, 8 & 10"
                    },
                    {
                        "text": "22 February 2021"
                    },
                    {
                        "text": "1.10"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Updated Appendix 10 & 14. Addition of Appendix 15."
                    },
                    {
                        "text": "10 March 2021"
                    },
                    {
                        "text": "1.11"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Addition of Appendix 16"
                    },
                    {
                        "text": "07 April 2021"
                    },
                    {
                        "text": "1.12"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Update to sections 7.6.5 and 7.6.6 in line with national protocol change. And MAC changed to MAG (new group name)"
                    },
                    {
                        "text": "16 April 2021"
                    },
                    {
                        "text": "1.13"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Appendix 9 removed, no longer required."
                    },
                    {
                        "text": "08 June 2021"
                    },
                    {
                        "text": "1.14"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Updated Appendix 2"
                    },
                    {
                        "text": "21 June 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 6,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "1.15"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Updated Appendix 13,14 and 16"
                    },
                    {
                        "text": "24 June 2021"
                    },
                    {
                        "text": "1.16"
                    },
                    {
                        "text": "Chris Overland"
                    },
                    {
                        "text": "Reinstatement of Appendix 9 as new version, Updated Appendix 10, Addition of appendices 17 and 18"
                    },
                    {
                        "text": "25 June 2021"
                    },
                    {
                        "text": "1.17"
                    },
                    {
                        "text": "Emma Sweetman"
                    },
                    {
                        "text": "Updated Appendix 17 as new version. Addition of appendices 19, 20 and 21"
                    },
                    {
                        "text": "20September 2021"
                    },
                    {
                        "text": "1.18"
                    },
                    {
                        "text": "Rich Ketley"
                    },
                    {
                        "text": "Update to appendix 2"
                    },
                    {
                        "text": "01 November 2021"
                    },
                    {
                        "text": "1.19"
                    },
                    {
                        "text": "Rich Ketley"
                    },
                    {
                        "text": "Update to appendix 16 and appendix 22 added."
                    },
                    {
                        "text": "23 November 2021"
                    },
                    {
                        "text": "1.20"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Addition of appendix 23"
                    },
                    {
                        "text": "01 December 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and Responsibilities within the Trust .................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "COVID-19 Vaccines .................................................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Legal framework and practice standards .................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Staff authorisation to be supplied with and administer COVID-19 Vaccines ............... 11"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Administration of COVID-19 Vaccines ........................................................................ 14"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Safety and security of vaccines and related medicines .............................................. 14  Ordering, Stock Control and monitoring of wastage ................................................... 14  Storage and transportation of vaccines ...................................................................... 15  Precautions ................................................................................................................. 15  Maintenance of Records ............................................................................................. 15  Data Protection ........................................................................................................... 16  Disposal of vaccines and other waste ......................................................................... 16  Incident and Adverse Drug Reaction Reporting .......................................................... 16  Workforce ................................................................................................................... 17  Business Continuity Planning ..................................................................................... 17  CQC Regulation 12: Safe Care and Treatment .......................................................... 17  Training Requirements ............................................................................................... 18  Monitoring and Audit ................................................................................................... 18  Approval and Implementation ..................................................................................... 18  Equality Impact Assessment ....................................................................................... 19  References ................................................................................................................. 19 Appendices \u2013 Stand-alone appendix document list ........................................................... 20 Appendix A: Preliminary Equality Analysis ......................................................................... 22"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The COVID-19 vaccination programme is of the highest priority for the NHS. In order to deliver this programme both safely and effectively, good practice in the handling and management of vaccine is paramount."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "It is anticipated that a number of COVID-19 vaccines will be introduced during 2020 and 2021, so good governance is essential."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Clarity of both the overarching principles and the detailed \u2018standard operating procedures' are required to enable safe, effective implementation and delivery of the vaccination programme."
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "This document is to be read alongside the Pharmacy Institutional Readiness documents (Guidance for Chief Pharmacists) which focus on the management of each of the individual COVID-19 vaccines, and the aligned Standard Operating Procedures developed for all vaccines and all environments in which the vaccines are handled."
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this document is to:"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Enable corporate and professional governance for use of the COVID-19 vaccines, with the expectation that all areas detailed are addressed locally and that standard NHS medicines governance arrangements are in place."
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Provide the overarching principles for robust governance of the safe and secure handling and management of COVID-19 vaccines in the end-to-end supply chain for the vaccination programme."
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "The objectives of this document are:"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that all staff involved in delivery of the vaccination programme are aware of, and adhere to, the correct procedures for the ordering, receipt, storage, supply and administration of the product."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that the physical and biochemical integrity and sterility of all vaccines and related medicines is maintained."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that all staff involved in delivery of the vaccination programme are aware of the relevant characteristics of COVID-19 vaccines and the implications this has for vaccine efficacy and patient safety."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To provide assurance that vaccine safety, sterility and efficacy is protected."
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To define key roles and responsibilities needed to deliver this assurance."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that all staff understand their critical roles and responsibilities in"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "delivering these objectives."
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "type": "table",
            "sequence_num": 36,
            "data": {
                "num_rows": 8,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "MHRA"
                    },
                    {
                        "text": "Medicines and Healthcare products Regulatory Agency"
                    },
                    {
                        "text": "ULT conditions"
                    },
                    {
                        "text": "Ultra low temperature"
                    },
                    {
                        "text": "\u2018cold chain'"
                    },
                    {
                        "text": "the cold temperature conditions in which certain products need to be kept during storage and distribution"
                    },
                    {
                        "text": "PGD"
                    },
                    {
                        "text": "Patient Group Direction; are written instructions for the supply or administration of medicines to groups of patients who may not be individually identified before presentation for treatment."
                    },
                    {
                        "text": "PHE"
                    },
                    {
                        "text": "Public Health England"
                    },
                    {
                        "text": "PSD"
                    },
                    {
                        "text": "Patient Specific Direction: is an instruction from a prescriber i.e. a doctor, dentist, or independent non-medical prescriber for medicines to be supplied and/or administered to a named patient after the prescriber has assessed the patient on an individual basis."
                    },
                    {
                        "text": "NP"
                    },
                    {
                        "text": "The \u2018National Protocol' is a new type of instruction that was introduced to support the expanded influenza and COVID-19 Vaccination Campaign. This is a new legal mechanism which has been put in place following amendment of the Medicines Regulations. It needs to be authorised in law by the UK Secretary of State for Health & Social Care. It will allow those who are registered healthcare professionals who cannot operate under a PGD, and those who are not registered healthcare professionals, to safely administer a licensed or temporarily authorised COVID-19 or influenza vaccine."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Individual responsibilities (i.e. Committees)"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.1 Medicines Assurance Group (MAG)"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To have documentation of the named individuals with responsibility and accountability for all aspects contained within this policy;"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure the effective implementation, use and timely review of this policy;"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure that monitoring arrangements are appropriately performed by the Site Pharmacy departments, and COVID-19 Hub Vaccine team service;"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where necessary, escalate concerns to the Deputy Chief Executive as appropriate;"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To exception report to the MSE Risk & Compliance Group or MSE Patient Safety & Quality Group (if needed) on developments, concerns and progress concerning the handling and management of the COVID-19 vaccine/s."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.2 COVID-19 Vaccine Delivery Group"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure safe, effective administration of COVID-19 Vaccine(s) as per this policy;"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To monitor distribution from vaccination centre;"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To manage all areas of clinical risk;"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To report and monitor all incidents and identify trends and themes;"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure timely reporting locally and nationally;"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure cascade of all information relation to COVID-19 Vaccine;"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To regularly report to MSE Quality Assurance Committee."
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.1.3 Pharmacy Directorate Board"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure safe, effective and secure supply of all medicines to all sites."
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To ensure the undertaking, communication of and supporting all locations in handling and management of COVID-19 vaccine/s."
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "To manage all aspects of COVID-19 vaccine/s service overseen by Pharmacy, under direction from Chief Pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "Individual responsibilities (i.e. Chief Executive)"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.1 The Chief Executive as the Accountable Officer has overall responsibility for the quality and safety of services provided by the Trust. In this respect, they are responsible for ensuring that the infrastructure required to support the delivery and implementation of this document is available. They will delegate the full implementation of this document to a relevant Executive Director."
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.2 The delegated responsibility is to the Deputy Chief executive."
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.3 Chief Medical Officer (delegated to each Site Medical Director)"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that there is policy compliance on site by all professions they oversee and that the service is operating effectively;"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring any escalated COVID-19 vaccine issues involving professions they oversee are appropriately managed corporately."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.4 Chief Nursing Officer (delegated to each Site Director of Nursing)"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinical oversight and responsibility for ensuring that the necessary systems, processes, training and competency assessment (where appropriate) are available to ensure that all non-medical staff and medical staff are able to comply with the contents of this document."
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.5 MSE Director of Operations"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Operational Oversight and accountability for the delivery of the vaccination sites."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for implementing this policy and monitoring impact on the service delivery and reporting compliance."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.6 Chief Pharmacist"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Professionally accountable for the safe and secure handling and management of medicines on all vaccination sites operating within or under the jurisdiction of their employing legal entity (i.e. The MSE Trust). This includes oversight of those elements of practice within mass vaccination centres and other designated vaccination sites that may impact upon product integrity, from receipt of product to vaccine administration."
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensures that appropriate and formal authorisation for vaccine administration is in place in line with section 7 of this policy."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensures that that safe and secure handling and storage of vaccine and medicines are in place in accordance with principles and guidance encompassed in \u2018Professional guidance on the safe and secure handling of medicines (Royal Pharmaceutical Society of Great Britain)'"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Establishes and maintains an agreed business continuity plan in relation to safe and secure handling of vaccines."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Escalates to NHS region incident reports involving COVID-19 vaccination, including decision of whether to enact the fast-track incident response pathway."
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Chief Pharmacist may delegate operational responsibility for oversight of ordering, receipt, storage and safe handling of vaccines and medicines, to a named and suitably trained pharmacy team member on each vaccination site."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.7 Designated Responsible Pharmacy Technician"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Must ensure that all activities are carried out in accordance with:"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.8 COVID-19 Vaccine Hub Team"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Head of vaccination and Testing team"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Matron for Vaccination and Testing Team"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for implementing this policy in the designated vaccination centres and for monitoring the impact on the service and reporting compliance with the document."
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The team are responsible for ensuring that all clinical staff working within the designated vaccination centre comply with the contents of this policy and for taking immediate action when this is not the case."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Clinical team within the COVID-19 Vaccination team are responsible to ensure that all necessary training is provided."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for escalation of any issues to the appropriate responsible"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "individuals named in section 4.2 of this policy."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for reporting all serious adverse events and defects to the Designated Responsible Pharmacy Technician and or Trust Chief Pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Timely incident reporting and submission of mandatory additional reports to Chief Pharmacist."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.9 Named individual in charge of a location"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Vaccination and testing Team Leader"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Team leader is accountable for the safe care and management of anyone attending the vaccination centre for COVID-19 vaccination. They are therefore responsible for ensuring that all staff within the vaccination centre fully comply with this document and for implementing a system to provide assurance that"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 0,
                "text": "this is always the case."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "4.2.10 Accountable individual"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Medical and non-medical clinical staff (working within the COVID-19 vaccination and testing team)"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Must be fully aware of this policy and adhere to this policy in relation to COVID- 19 vaccine and management. They must identify immediately to their managers any aspect of the policy or procedure they do not feel competent in."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "COVID-19 Vaccines"
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "There are a number of COVID-19 vaccines under development and it is anticipated that a range will be utilised in the vaccination programme."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "None will be authorised at the start of the programme so initially they will come into use under Regulation 174 of the Human Regulations 2012. This regulation enables the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise use of a product on a temporary basis in response to the spread of pathogenic agents."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "The characteristics of the different vaccines may vary considerably and will increase in clarity over time."
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Prior to licensing the product characteristics are available in the relevant \u2018Healthcare Professional Factsheet' and patient information in the \u2018Consumer Factsheet'. Following award of the Marketing Authorisation this information is available in the Summary of Product Characteristics and Patient Information leaflet respectively."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "The Pfizer Biotech vaccine requires transport and storage under ULT (ultra-low temperature) conditions (-70 +/- 10\u00b0 C). This may not be the case for all COVID-19 vaccines, but cold chain will be critical for all."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "Use of vaccines that have deviated from recommended storage or transportation conditions risks compromising vaccine efficacy and patient safety."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "Vaccines that have not been transported or stored correctly may be ineffective or harmful; they would therefore no longer be within the terms of their product authorisation and must not be used."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "The focus on avoidance of waste should also be of high priority."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.9,
                "text": "Further information concerning COVID-19 vaccines is available in the Public Health England publication \u2018COVID-19 vaccination programme Information for healthcare practitioners', available on https://www.gov.uk/government/publications/covid-19- vaccination-programme-guidance-for-healthcare-practitioners ."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Legal framework and practice standards"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "All activity is undertaken in accordance with the Human Medicines Regulations 2012 and Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "All activity is aligned with relevant COVID-19 Vaccination Programme NHS policy documents marked as Classification: Official and annotated with a publication approval reference number."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "In addition, adherence to national standards of good practice is required including those set by the Care Quality Commission, the National Institute for Health and Care Excellence, Public Health England and the Royal Pharmaceutical Society of Great Britain."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "The vaccine is a prescription only medicine (POM) which cannot be administered or supplied to patients unless one of four types of instruction is in place:"
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a) a signed Prescription;"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "b) a signed Patient Specific Direction (PSD);"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "c) a Patient Group Direction (PGD);"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "d) a National protocol (applies to influenza and COVID-19 vaccines only)."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Staff authorisation to be supplied with and administer COVID-19"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Vaccines"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Formal authorisation for vaccine administration is in place and this will either be a Patient Group Direction (PGD), protocol or written instruction. It is ensured that the staff groups who are supplied with, prepare, and administer the COVID-19 vaccine are those defined as eligible to do so."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "In order to manage the period between the commencement of the vaccination programme and the availability of the national PGD or national protocol; which will be the overarching strategic prescribing approach for the mass vaccination programme, it is necessary to implement a short-term interim step to support the delivery of vaccines until the relevant legal documents are available."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "Therefore a Patient Specific Direction (PSD) mechanism, based on the framework agreed in this policy, is used to prescribe the vaccine until the national PGD/ national protocol is available. This provides the legal mechanism for the administration of the vaccine as a short-term interim measure."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.4,
                "text": "Patient Specific Direction (PSD)"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.1 A PSD is used for administration of medicines only. A PSD for the supply of medicines is classified as a prescription form. This form is a legal document and supply must comply with the legislation for the validity of prescriptions."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.2 The Trust recognises and accepts that the use of a PSD to support vaccine delivery is not a long-term viable solution due to the following reasons:"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a) Prescribers need to be medical practitioners, Independent nurse or pharmacist prescribers (who are suitably trained with experience in immunisation) limiting the number of staff who can prescribe."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "b) A prescriber will need to give an authorised instruction to administer a medicine to a list of individually named patients where each patient on the list has been individually assessed by that prescriber."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "c) There is no restriction in law as to who can administer the medicine to the patient, under a PSD however the prescriber has a duty of care and is professionally and legally accountable for the care, he/she provides, including tasks delegated to others. Therefore, the prescriber must be satisfied that the person to whom practice is delegated has the qualifications, experience, knowledge and skills to provide the care or treatment involved."
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.3 With a PSD the prescriber takes full accountability and responsibility for the patient and the members of staff administering the vaccine; unlike in a PGD or National Protocol, where staff would be taking responsibility for their own tasks. In practice professions are only likely to take on responsibility for others when that person is known to them and they are aware of their competency/skills and training. It is therefore essential that prescriber is content with taking on this responsibility and that there is no suggestion of expectation for them to take on this role. This should be confirmed with each prescriber at the start of a vaccination session."
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.4 Any PSD for the purpose of COVID-19 vaccination will be managed and approved in accordance with the principles of MSEPO-20210 Development Approval and Implementation of PGDs Policy, without exception."
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.5 For approved Patient Specific Directions, which are different for each vaccine type, please refer to the appendices of this policy."
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.5,
                "text": "Patient Group Directions (PGDs)"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.1 PGDs are written instructions for the supply or administration of medicines to groups of patients who may not be individually identified before presentation for treatment. They provide a legal framework that allows the supply and/or administration of a specified medicine(s), to a pre-defined group of patients needing prophylaxis or treatment for a condition described in the PGD, without the need for a prescription or an instruction from a prescriber."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.2 Any PGD for the purpose of COVID-19 vaccination will be managed and approved in accordance with MSEPO-20210 Development Approval and Implementation of PGDs Policy, without exception."
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.3 PGDs can usually only be used for licensed medicines. The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 regulations (October 2020) allows the registered healthcare workforce that already operates under PGDs"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "to deliver vaccinations to continue to do so in the case of an unlicensed or temporarily authorised COVID-19 vaccine."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.4 The national COVID-19 Vaccine PGD is currently being developed by Public Health England and will follow an expedited process for development and publication once the required vaccine characteristic details are published."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.6,
                "text": "National Protocol"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.1 A National Protocol is a new type of instruction that was introduced to support the expanded influenza and COVID-19 Vaccination Campaign. This is a new legal mechanism which has been put in place following amendment of the Medicines Regulations."
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.2 The \u2018national protocol' needs to be authorised in law by the UK Secretary of State for Health & Social Care. It will allow those who are registered healthcare professionals who cannot operate under a PGD, and those who are not registered healthcare professionals, to safely administer a licensed or temporarily authorised COVID-19 or influenza vaccine."
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.3 This protocol is being developed by Public Health England (PHE) and will be written similarly to a PGD. It would provide the flexibility to define the training and competence requirements of vaccinators. It also allows the process of administration to be split into its component parts i.e. clinical assessment and consent, preparation of the vaccine and administration of the vaccine."
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.4 All these stages outlined in 7.6.3 can be done by one competent person (the registered healthcare professional). However in the case of large vaccination centres these tasks can be split with each person trained and authorised to complete their specific task as defined in the protocol. The clinical assessment and consent process must only be undertaken by a registered healthcare professional. The preparation of the vaccine must only be undertaken and overseen by those registered healthcare professionals trained in aseptic technique; and have the competency skills for dilution and drawing up as required by the vaccine."
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.5 A clinical supervisor, who must be a registered doctor, nurse or pharmacist trained and competent in all aspects of the protocol, must be present and take overall responsibility for provision of vaccination under the protocol at all times and be identifiable to service users. The drawing up of the vaccine has its own supervision requirements in accordance with Part 1 of the HMR 2012 and will need to be done by, or under the supervision of, a registered doctor, nurse or pharmacist. If a vaccination service is being provided at scale, the clinical supervisor should only take on specific supervision requirements in relation to the drawing up of the vaccine if this can be done safely alongside their overarching role. Any time the protocol is used, the name of the clinical supervisor taking responsibility and all the people working under different stages of the protocol must be recorded for the session."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.6 The clinical supervisor has ultimate responsibility for safe care being provided under the terms of the protocol. Staff working under the protocol may be supported by additional registered healthcare professionals, but the clinical supervisor retains overall responsibility. Staff working to the protocol must understand who the clinical supervisor for their practice at any time is and can only proceed with their authority. The clinical supervisor may withdraw this authority for all members of staff or individual members of staff at any time and has authority to stop and start service provision under the protocol as necessary. Every member of staff has a responsibility to, and should, report immediately to the clinical supervisor any concerns they have about working under the protocol in general or about a specific individual, process, issue or event."
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Administration of COVID-19 Vaccines"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "It is imperative that the conditions of temporary authorisation of the COVID-19 vaccines by the MHRA are followed. Each vaccine will have its own specific requirements."
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.2,
                "text": "Refer to COVID 19 Vaccine specific SOP for administration (see various appendices, specific to each vaccine type)."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.3,
                "text": "All administration must be in line with existing Trust and legacy Trust/site policies for the Administration of Medicines (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "Vaccine Supervisors must follow the specific Vaccine Supervisor checklist (see various appendices, specific to each vaccine type)."
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Safety and security of vaccines and related medicines"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Safe and secure handling and storage of vaccine and medicines are in place in accordance with principles and guidance encompassed in \u2018Professional guidance on the safe and secure handling of medicines (Royal Pharmaceutical Society of Great Britain)"
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.2,
                "text": "Refer also to MSEPO-20205 Trust Policy for Safe and Secure Storage of Medicines."
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Ordering, Stock Control and monitoring of wastage"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Please refer also to MSEPO-20205 Trust Policy for Safe and Secure Storage of Medicines."
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "Please refer to the Vaccine Supervisor checklist (see various appendices, specific to each vaccine type)."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.3,
                "text": "Please refer to the Vaccine Requisition and Collection Form (see various appendices, specific to each vaccine type)."
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.4,
                "text": "Orders to the Pharmacy Vaccine Hub should be made by authorised staff in accordance with the relevant pharmacy paperwork and order schedule."
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.5,
                "text": "Expired and Wasted vials must always be documented on the designated form when returned to pharmacy (appendix 5)."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 1,
                "text": "11 Storage and transportation of vaccines"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "Maintaining the cold chain ensures that vaccines are transported and stored according to the manufacturer's recommended temperature range until the point of administration."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "Vaccines must be stored at the correct temperature and transported only in approved and validated packaging, and the temperature of the vaccine carrier and contents monitored."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "Refer also to MSEPO-20205 Trust Policy for Safe and Secure Storage of Medicines."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Precautions"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "Anaphylaxis kits, where existing drugs are unavailable, including injections of intramuscular adrenaline 1:1,000, must be in date and readily available at all locations undertaking vaccination. Date checking is the responsibility of the named individual in charge of that location."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Any needlestick or other injuries must be addressed in accordance with the Trust site policy for the management of occupational sharps and contamination injuries (or equivalent)."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Maintenance of Records"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "All records must be maintained in accordance with relevant SOPs. These include the ordering, receipt and issue of vaccines, tracking of product, plus patient focused records including consent and administration."
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "All completed PSDs must be returned to the Pharmacy Vaccine Hub for record keeping."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.3,
                "text": "Any serious adverse reactions are to be escalated for immediate senior clinical input; such situations are to be fully documented following the event and a record kept of relevant product batch numbers. See also section 16"
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.1 A record of all serious adverse events and defects must be provided to the Designated Responsible Pharmacy Technician by the COVID-19 Vaccine Hub Team and reported via the MHRA Yellow card reporting mechanism. See also Section 16."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Data Protection"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "All staff have a responsibility to ensure that they do not disclose information about the service, service users, staff members and corporate documentation to unauthorised individuals."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "All staff must be compliant with all Trust Information Governance policies and associated documents."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Disposal of vaccines and other waste"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Disposal of waste vaccines and any sharps must be undertaken in a safe and secure manner in accordance with relevant SOPs."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "Where packaging includes dry ice this must also be disposed of in a safe and secure manner using appropriate personal protective equipment as detailed in the relevant SOP."
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Incident and Adverse Drug Reaction Reporting"
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "All incidents must be reported in line with the relevant Trust policies: MSEPO-19014 Policy for Management of Incidents, MSEPO-19015 Procedure Report Management of Incidents and Serious Incidents and MSEPO-20206 Management of Learning from Medication Error Incidents."
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.2,
                "text": "Incidents at all vaccination centres and the pharmacy vaccine hub must be reported on the Trust incident reporting system (Datix or Ulysses depending on site). An additional reporting process must also be completed and submitted to the Chief Pharmacist following the procedure in appendix 6, and using the proforma (appendix 7)."
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.3,
                "text": "Additionally all vaccination centres must report all clinical incidents using the MHRA Yellow Card system."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.4,
                "text": "Submission via the Trust Chief Pharmacist ensures escalation to national level via the National Incident Coordination Centre Single Point of Contact (ICC SPOC)."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.5,
                "text": "The Chief Pharmacist will escalate all relevant incidents from the Trust in line with the current COVID-19 Vaccination Clinical Workstream Standard operating procedure: Management of COVID-19 vaccination clinical incidents and enquiries. (NHS England and NHS Improvement)."
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Workforce"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "The roles assigned to support the rollout of COVID-19 vaccination are in accordance with legislation including that detailed in the Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "Named individuals must ensure that accountable individuals are competent and supported in their role as it relates to the safe and secure handling of medicines'."
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Business Continuity Planning"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "An agreed business continuity plan in relation to safe and secure handling of vaccines is in place. It is tested in line with the organisational emergency preparedness processes and NHS Core Standards for Emergency Preparedness, Resilience and Response (https://www.england.nhs.uk/ourwork/eprr/gf/)."
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.2,
                "text": "The business continuity plan details how the service will respond, recover and manage its services during disruption relating to people, information, security, premises including utilities, facilities particularly ULT and refrigerator failure, supplier, IT and data."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "CQC Regulation 12: Safe Care and Treatment"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.1,
                "text": "National Standard acknowledgement"
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.1.1 The intention of this regulation is to prevent people from receiving unsafe care and treatment and prevent avoidable harm or risk of harm. The Trust must assess the risks to people's health and safety during any care or treatment and make sure that staffs have the qualifications, competence, skills and experience to keep people safe."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.1.2 The Trust must make sure that the premises and any equipment used is safe and where applicable, available in sufficient quantities. Medicines must be supplied in sufficient quantities, managed safely and administered appropriately to make sure people are safe."
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.1.3 The Trust must prevent and control the spread of infection. Where the responsibility for care and treatment is shared, care planning must be timely to maintain people's health, safety and welfare."
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "text": "19.1.4 The CQC understands that there may be inherent risks in carrying out care and treatment, and they will not consider it to be unsafe if the Trust can demonstrate that they have taken all reasonable steps to ensure the health and safety of people using their services and to manage risks that may arise during care and treatment'"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "All staff undertaking duties at the vaccination site must meet the necessary training standards and competencies in line with the SOPs and standard Trust processes."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "The national training module is COVID-19 Vaccination - e-Learning for Healthcare (hosted by e-lfh.org.uk)."
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.3,
                "text": "A training needs assessment is required for the roles within the vaccination services, with corresponding training materials and assessment process, to enable timely and focussed workforce development."
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "Outlined  below  is  the  Trust's  process  of  monitoring  compliance  with,  and  the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "type": "table",
            "sequence_num": 196,
            "data": {
                "num_rows": 4,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Expired or wasted vials"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "Weekly"
                    },
                    {
                        "text": "Quality Assurance Committee COVID-19 Vaccine Delivery Group"
                    },
                    {
                        "text": "Quality Assurance Committee COVID-19 Vaccine Delivery Group"
                    },
                    {
                        "text": "Process of handling and adminsitration"
                    },
                    {
                        "text": "Incidents"
                    },
                    {
                        "text": "Chief Pharmacist"
                    },
                    {
                        "text": "Daily"
                    },
                    {
                        "text": "COVID-19 Vaccine Delivery Group MSE Medicines Assurance Group"
                    },
                    {
                        "text": "Quality Assurance Committee COVID-19 Vaccine Delivery Group"
                    },
                    {
                        "text": "PSD Completion"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Pharmacy"
                    },
                    {
                        "text": "Weekly"
                    },
                    {
                        "text": "COVID-19 Vaccine Delivery Group MSE Medicines Assurance Group"
                    },
                    {
                        "text": "Quality Assurance Committee COVID-19 Vaccine Delivery Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "All policies, procedures and guidelines will be approved by the Medicines Assurance Group (or equivalent), which is the specialist group with the authority to approve local medication documents. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.2,
                "text": "It is the author's responsibility to inform the relevant clinical teams of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 23.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 6)"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.1,
                "text": "Care Quality Commission (2020) Guidance to providers: Regulation 12: Safe Care and Treatment. Available on https://www.cqc.org.uk/guidance-providers/regulations- enforcement/regulation-12-safe-care-treatment [Accessed 02/12/2020]."
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.2,
                "text": "NHS Specialist Pharmacy Service (2020). Pharmacy Institutional Readiness for Management of Pfizer-BioNTech (Courageous) Covid-19 vaccine. Guidance for Chief Pharmacists [Accessible only via Chief Pharmacist (Confidential-sensitive)."
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.3,
                "text": "NICE (2014). Clinical Guideline QS61: Infection Prevention and Control Available on https://www.nice.org.uk/guidance/qs61 [Accessed 02/12/2020]."
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.4,
                "text": "Public Health England (2020). The Green Book - Immunisation against infectious disease https://www.gov.uk/government/collections/immunisation-against- infectious-disease-the-green-book#the-green-book [Accessed 02/12/2020]. The latest information on vaccines and vaccination procedures, for vaccine preventable infectious diseases in the UK. The COVID-19 vaccine chapter is available on: https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.5,
                "text": "Royal Pharmaceutical Society (2018). Professional guidance on the safe and secure handling of medicines. Available on https://www.rpharms.com/recognition/setting-professional-standards/safe-and- secure-handling-of-medicines/professional-guidance-on-the-safe-and-secure- handling-of-medicines. [Accessed 02/12/2020]."
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 24.6,
                "text": "The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020"
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendices \u2013 Stand-alone appendix document list"
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 1: Patient Specific Direction for the administration of Pfizer BioNTech COVID-19 mRNA Vaccine BNT 162b2"
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 2: Standard Operating Procedure for Preparation of Pfizer-BioNTech COVID-19 mRNA Vaccine BNT 162b2 syringes for Administration"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 3: Vaccine Supervisor Checklist for Pfizer BioNTech COVID-19 vaccine"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 4: Pfizer-BioNTech COVID-19 mRNA BNT162b2 vaccine requisition and collection form Appendix 5: Expired and Wasted COVID-19 vaccine form"
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 6: Standard Operating Procedure for Reporting of COVID-19 Vaccination incidents"
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 7: East of England: COVID-19 Vaccination RVOC Incident Notification and Reporting Proforma"
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 8: Standard Operating Procedure for Management of medicines in the event of an evacuation of COVID-19 Vaccination Centres"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 9: Patient Specific Direction for the administration of COVID-19 Vaccine AstraZeneca, (ChAdOx1S [recombinant])"
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 10: Standard Operating Procedure for preparation of AstraZeneca COVID-19 Vaccine syringes for Administration"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 11: Vaccine Supervisor Checklist for AstraZeneca COVID-19 Vaccine Appendix 12: Vaccine requisition and collection form"
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 13: Standard Operating Procedure for Management of multiple COVID-19 vaccine types in vaccination centres"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 14: COVID-19 Vaccine change checklists"
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 15: COVID-19 Vaccination Clinic Safety Briefing Agenda"
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 16: Standard Operating Procedure for preparation of Moderna COVID-19 Vaccine syringes for Administration"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 17: COVID-19 Vaccination centre end of session checklist Appendix 18: Patient Specific Direction Moderna COVID 19 vaccine Appendix 19: Flu Vaccine Requisition and Collection Form"
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 20: Standard Operating Procedure for the Preparation of influenza (flu) vaccine syringes for administration"
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 21: Standard Operating Procedure for Fridge Temperature Monitoring in the Vaccination Centre"
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 22: Standard Operating Procedure for Preparation of Moderna (Spikevax) COVID-19 Vaccine syringes for Administration \u2013 0.25mL Booster Doses"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 23: Moderna Spikevax\u00ae COVID-19 Vaccine: Vaccine Requisition and Collection Form"
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "text": "COVID-19 Vaccine Handling and Management Policy / MSEPO20252 / 1.20"
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 24.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "text": "COVID-19 Vaccine Handling and Management Policy / MSEPO20252 / 1.20"
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix A: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to COVID-19 Vaccine Handling and Management Policy / MSEPO20252: (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "type": "table",
            "sequence_num": 235,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing policy"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new policy"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 236,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Introduce framework for delivery of COVID-19 vaccine"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "National requirement \u2013 provide required framework dictated nationally"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "All staff and relevant patient groups (in line with national requirement)"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No \u2013 extensive SOPs and policy content nationally standardised."
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "See page 2"
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "See page 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 237,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Richard Ketley"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Principal Pharmacist Medication Safety & MSO"
                    },
                    {
                        "text": "04 December 2020"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 238
        }
    ]
}